Scope
NICE NG143 assesses fever in children under five by clinical risk rather than temperature alone. It prioritizes immediate threats, age-specific risk, recognition of focal infection and a traffic-light assessment to guide referral and investigation. Young infants require a distinct pathway. Antipyretics are for distress, and every home-care decision needs clear follow-up and return advice.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Assess physiology and age-specific risk first
- First identify compromised airway, breathing or circulation and reduced consciousness. If fever suggests possible sepsis, use the dedicated paediatric sepsis pathway. Measure temperature, heart rate, respiratory rate and capillary refill. [1]
- Below 4 weeks, use an electronic axillary thermometer. From 4 weeks to 5 years, suitable methods include electronic or chemical-dot axillary measurement or infrared tympanic measurement. Do not routinely use oral or rectal measurement, and take parental reports of fever seriously. [1]
- Any red feature places a child at high risk; amber features without red features imply intermediate risk. Low risk requires green features without amber or red. Red findings include abnormal colour, poor responsiveness, inability to stay awake, grunting, severe chest indrawing, respiratory rate above 60/minute, reduced skin turgor or bulging fontanelle. [1]
- A temperature of at least 38°C below age 3 months is high risk; at least 39°C at ages 3–6 months is at least intermediate risk. Above 6 months, temperature height alone does not identify serious illness. [1]
- Capillary refill of at least 3 seconds is an amber marker. Tachycardia is also at least intermediate risk: over 160/min below 12 months, over 150/min at 12–24 months, and over 140/min at ages 2–5 years. Assess dehydration and obtain blood pressure when pulse or refill is abnormal and measurement is available. [1]
Look for a source and important alternative diagnoses
- Fever with a non-blanching rash raises concern for meningococcal disease, particularly with illness, purpura, prolonged refill or neck stiffness. Consider meningitis with neck stiffness, a bulging fontanelle, reduced consciousness or convulsive status; classic signs may be absent in infants. [1]
- Consider herpes simplex encephalitis with fever plus focal neurological signs, focal seizures or reduced consciousness. Consider bone or joint infection with swelling, non-use of a limb or refusal to bear weight. [1]
- Consider pneumonia with age-related tachypnoea, crackles, flaring, indrawing, cyanosis or room-air saturation at or below 95%. Also consider UTI in a febrile child under five and use the dedicated urine-testing pathway. Ask about travel and imported-infection exposure. [1]
- Assess fever lasting at least 5 days for Kawasaki disease. Ask about conjunctivitis, oral changes, rash, extremity changes and cervical nodes even if they have resolved; infants under one year may have fewer features yet greater coronary risk. [1]
Match the urgency of assessment to risk
- With immediately life-threatening symptoms, arrange emergency care at once. During remote assessment, red features without an immediate life threat require face-to-face assessment within 2 hours; amber features also need face-to-face review, with urgency determined clinically. [1]
- For a non-paediatric practitioner, red features require urgent paediatric referral. With amber findings and no diagnosis, arrange specialist assessment or a safety net including warning signs, a definite review plan or direct re-access to care. Green-only children may be managed at home with advice. [1]
- Do not prescribe oral antibiotics for fever without an apparent source. Suspected meningococcal disease needs parenteral antibiotics at the earliest opportunity and urgent specialist care. [1]
Use the separate pathway below three months
- Observe febrile infants below 3 months and record vital signs. Investigate with full blood count, blood culture, CRP and urine testing; obtain chest radiography only with respiratory signs and stool culture when diarrhoea is present. [1]
- Unless contraindicated, perform lumbar puncture in febrile infants below 1 month, and at 1–3 months if unwell or WBC is below 5 × 10^9/L or above 15 × 10^9/L. Perform it promptly and, when possible, before antibiotics. These infant groups also need parenteral antibiotics. [1]
- When parenteral antibiotics are indicated below 3 months, the guideline specifies a third-generation cephalosporin plus Listeria-active treatment. Selection must follow the relevant neonatal safety requirements and local resistance guidance; this summary does not supply a dose regimen. [1]
Tailor specialist tests and reassessment to risk
- At age 3 months or older with fever without source and red features, obtain blood count, culture, CRP and urine tests; consider lumbar puncture, chest radiography, electrolytes and blood gas according to the clinical findings. [1]
- For children aged at least 3 months: for specialist-assessed fever without source and amber features, obtain urine testing, blood count, CRP and cultures unless an experienced paediatrician judges them unnecessary. Consider lumbar puncture below one year; chest radiography is specified when fever exceeds 39°C and WBC exceeds 20 × 10^9/L. [1]
- For children aged at least 3 months: in the green specialist-referred group with fever without source, test urine and assess for pneumonia, but do not routinely order blood tests or chest radiography. In hospital, reassess amber or red children after 1–2 hours; response to antipyretics does not distinguish serious from minor illness. [1]
- Fever with shock in specialist or emergency care requires an immediate IV fluid bolus of 10 mL/kg, normally 0.9% sodium chloride initially, with active monitoring and further treatment as needed. Shock, unrousability or meningococcal signs require immediate parenteral antibiotics; suspected HSV encephalitis requires IV aciclovir. [1]
Treat distress and provide clear return advice
- Use paracetamol or ibuprofen for distress rather than the temperature number alone. Continue only while distressed, do not give both together, and consider alternating only if distress persists or recurs before the next dose. Antipyretics do not prevent febrile seizures. [1]
- Do not use tepid sponging or underdress/overwrap the child. Offer regular fluids or breast milk, teach dehydration signs and non-blanching-rash recognition, and check the child overnight. [1]
- Seek further help for a fit, non-blanching rash, deterioration, increased parental concern, fever lasting at least 5 days or difficulty caring for the child. Admission decisions also need family circumstances, repeated attendance and clinical concern, beyond the traffic-light signs alone. [1]
Limitations and use
- This is a selected clinical summary, not every traffic-light criterion or a complete sepsis, neonatal antimicrobial or tropical-fever protocol. Use the dedicated pathways when those conditions are suspected.
- Laboratory thresholds do not replace clinical assessment, and a falling temperature after medication does not establish low risk. Dose schedules, antibiotic contraindications and complete fluid-escalation limits are not provided.
- The guidance is from a UK setting and includes older retained recommendations; local resistance, epidemiology, referral capacity and current disease-specific guidance must inform application.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Fever in under 5s: assessment and initial management
Selected recommendation material consulted
Publication details
- Issuing organisation
- NICE
- First published
- 7 November 2019
- Publisher’s latest update
- 26 November 2021
- Resource type
- Clinical guideline · House clinical summary
- Source setting
- United Kingdom
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.